Clinical trial
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Name
STUDY00146119
Description
The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.
Trial arms
Trial start
2020-11-02
Estimated PCD
2025-10-26
Trial end
2026-10-26
Status
Recruiting
Phase
Early phase I
Treatment
Hyperpolarized Xe129
During MRI scanning, subject will inhale hyperpolarized xenon gas for a maximum of 16 seconds per scan, with a maximum of 4 MR scans + Calibration in a given imaging session.
Arms:
Hyperpolarized 129Xe
Other names:
HP Xenon
Size
260
Primary endpoint
RBC/Barrier Ratio
Day 1
Eligibility criteria
Inclusion Criteria:
Healthy Volunteers:
* Subject has no diagnosed pulmonary conditions
* Ability to read and understand English or Spanish
Subjects with Lung Disease:
* Subject has a diagnosis of pulmonary dysfunction made by a physician
* No acute worsening of pulmonary function in the past 30 days
* Ability to read and understand English or Spanish
Exclusion Criteria:
* MRI is contraindicated based on responses to MRI screening questionnaire
* Subject is pregnant or lactating
* Subject does not fit into 129Xe vest coil used for MRI
* Subject cannot hold his/her breath for 15-16 seconds
* Subject deemed unlikely to be able to comply with instructions during imaging
* Oxygen saturation \<88% on room air or with supplemental oxygen
* Cognitive deficits that preclude ability to provide consent
* Institutionalization
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'DIAGNOSTIC', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 260, 'type': 'ESTIMATED'}}
Updated at
2024-06-10
1 organization
1 product
7 indications
Organization
Mario CastroProduct
Hyperpolarized Xe129Indication
AsthmaIndication
Chronic Obstructive Pulmonary DiseaseIndication
Interstitial Lung DiseaseIndication
Cystic FibrosisIndication
Pulmonary HypertensionIndication
Pulmonary InfectionIndication
Other Lung Disease